Bank of New York Mellon Corp bought a new position in DNOW Inc. (NYSE:DNOW - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 1,147,755 shares of the oil and gas company's stock, valued at approximately $14,886,000. Bank of New York Mellon Corp owned approximately 0.63% of DNOW as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also added to or reduced their stakes in the company. Quarry LP raised its holdings in shares of DNOW by 712.6% during the 4th quarter. Quarry LP now owns 1,942 shares of the oil and gas company's stock valued at $26,000 after buying an additional 1,703 shares in the last quarter. Sunbelt Securities Inc. grew its position in DNOW by 8,060.0% during the first quarter. Sunbelt Securities Inc. now owns 2,448 shares of the oil and gas company's stock valued at $29,000 after acquiring an additional 2,418 shares during the last quarter. Clearstead Advisors LLC raised its stake in shares of DNOW by 132.5% during the fourth quarter. Clearstead Advisors LLC now owns 2,427 shares of the oil and gas company's stock worth $32,000 after acquiring an additional 1,383 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in shares of DNOW by 190.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,423 shares of the oil and gas company's stock worth $36,000 after acquiring an additional 1,589 shares during the last quarter. Finally, Arax Advisory Partners boosted its stake in shares of DNOW by 336.3% in the 4th quarter. Arax Advisory Partners now owns 2,797 shares of the oil and gas company's stock valued at $37,000 after purchasing an additional 2,156 shares in the last quarter. Institutional investors own 97.63% of the company's stock.
Key Headlines Impacting DNOW
Here are the key news stories impacting DNOW this week:
- Negative Sentiment: Multiple firms, including Pomerantz, Hagens Berman and Schall, Brown & Schwartz, reminded investors of the lawsuit, which alleges violations of federal securities laws, including Sections 10(b) and 20(a) and SEC Rule 10b-5. The allegations create uncertainty around DNOW’s disclosure practices and could expose the company to legal costs or potential damages. Pomerantz investor alert SBS investor notice
- Negative Sentiment: The litigation appears tied to DNOW’s 2025 MRC Global transaction and claims that investors were not informed of material ERP integration problems before voting at the September 9, 2025 special meeting. Renewed coverage by multiple law firms is likely weighing on sentiment because it highlights potential merger-related liabilities and governance concerns. Hagens Berman investor alert
- Neutral Sentiment: October 2, 2026 is the lead-plaintiff deadline. Rosen Law Firm said investors who held DNOW shares as of August 5, 2025, and were entitled to vote at the special meeting, may seek lead-plaintiff status or potential compensation. The law-firm announcements do not establish that DNOW committed wrongdoing; the claims remain allegations. Investor deadline notice
Analysts Set New Price Targets
Several research firms have weighed in on DNOW. Weiss Ratings reissued a "sell (d+)" rating on shares of DNOW in a research note on Monday, August 24th. Zacks Research upgraded DNOW from a "strong sell" rating to a "hold" rating in a report on Friday, May 22nd. Wall Street Zen upgraded DNOW from a "sell" rating to a "hold" rating in a research report on Saturday, August 8th. Freedom Capital upgraded DNOW to a "strong-buy" rating in a research report on Monday, June 22nd. Finally, Susquehanna increased their price objective on DNOW from $16.00 to $19.00 and gave the company a "positive" rating in a research note on Friday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, DNOW presently has an average rating of "Moderate Buy" and an average target price of $18.25.
Get Our Latest Report on DNOW
DNOW Stock Down 0.9%
DNOW stock opened at $15.88 on Wednesday. The firm has a market cap of $2.87 billion, a PE ratio of -14.84 and a beta of 0.87. The business has a 50 day moving average of $14.50 and a 200 day moving average of $13.41. DNOW Inc. has a twelve month low of $10.94 and a twelve month high of $17.26. The company has a quick ratio of 1.06, a current ratio of 2.14 and a debt-to-equity ratio of 0.23.
DNOW (NYSE:DNOW - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The oil and gas company reported $0.12 earnings per share for the quarter, beating analysts' consensus estimates of $0.09 by $0.03. DNOW had a negative net margin of 4.58% and a positive return on equity of 3.91%. The business had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.27 billion. DNOW's revenue was up 108.1% compared to the same quarter last year. During the same period last year, the business earned $0.27 EPS. On average, research analysts forecast that DNOW Inc. will post 0.34 EPS for the current fiscal year.
DNOW Profile
(
Free Report)
DistributionNOW NYSE: DNOW is a global distributor of energy and industrial products, serving a broad range of end-markets including oil and gas, petrochemical, power generation, and industrial manufacturing. Headquartered in Houston, Texas, the company provides solutions across the life cycle of energy and industrial assets, with an emphasis on safety, reliability and operational efficiency.
The company’s core product portfolio includes piping systems and related components (such as valves, fittings, flanges and gaskets), instrumentation, electrical and automation equipment, fasteners, industrial safety supplies, chemicals and composite products.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider DNOW, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DNOW wasn't on the list.
While DNOW currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.